Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Silence Therapeutics plc SLN

Set alert

Price alert · SLN

All alert types
19.76 USD +0.01 +0.05%

At close

19.22 -0.54 -2.73%

Pre-market · Nov 3, 4:00 AM ET

Bid
19.76 × 2
Ask
19.77 × 2
19.75 Day range 19.80
4.19 52-week range 19.87
YTD
+225.00%
1 year
+198.94%
Open
19.75
Prev close
19.75
Mkt cap
1.23B
Vol
1.19M
Avg vol
2.78M
EPS
-1.29
P/E
0.00
Div yield
0.00%
More statistics
Low
19.75
High
19.80
Forward P/E
-52.00
Beta
1.34
Short ratio
2.70
Inst. own
47.74%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
13.48
200-d avg
9.06
1y target
19.75

5D chart

Chart tools
Interval
1m5m15m30m

Signals (34)
NameTimeAgo
SMA: BullishNov 2, 9:30 AM23 hours ago
MACD: Buy SignalNov 2, 9:30 AM23 hours ago
RSI: OversoldOct 30, 3:10 PM3 days ago
SMA: BearishOct 30, 2:05 PM3 days ago
MACD: Sell SignalOct 30, 12:55 PM3 days ago
MACD: Buy SignalOct 30, 11:00 AM3 days ago
MACD: Sell SignalOct 30, 9:50 AM3 days ago
RSI: OverboughtOct 29, 3:40 PM4 days ago
RSI: OverboughtOct 29, 3:25 PM4 days ago
MACD: Buy SignalOct 29, 2:45 PM4 days ago
SMA: BullishOct 29, 12:45 PM4 days ago
MACD: Sell SignalOct 29, 12:25 PM4 days ago
MACD: Buy SignalOct 29, 11:05 AM4 days ago
MACD: Sell SignalOct 29, 10:50 AM4 days ago
MACD: Buy SignalOct 29, 9:35 AM4 days ago
SMA: BullishOct 29, 9:30 AM5 days ago
RSI: OversoldOct 28, 3:55 PM5 days ago
MACD: Sell SignalOct 28, 3:50 PM5 days ago
MACD: Buy SignalOct 28, 2:50 PM5 days ago
MACD: Sell SignalOct 28, 1:35 PM5 days ago

Newest 20 of 34.

Analyst view

Consensus: hold

Hold
Price target (mean) 19.75 -0.1% downside
Target (low)
19.00
Target (mean)
19.75
Target (high)
20.00
Ratings (0m) 5 1 buy · 4 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold4
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 7
  • 2 months ago 7

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

SLN analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.09-0.09 – -0.09-0.15+40.0%20.83K-82.8%1
Next quarter-0.10-0.10 – -0.10-0.27+63.0%4.50K-82.3%1
Current year-0.365-0.37 – -0.36-1.85+80.3%328.76K-21.4%2
Next year-0.38-0.38 – -0.38-0.365-4.1%760.45K+131.3%2

Upgrades and downgrades

The latest rating changes

SLN analyst upgrades and downgrades
DateFirmActionFromTo
Oct 21, 2026HC Wainwright & Co.DowngradeBuyNeutral
Aug 11, 2026Morgan StanleyMaintainedOverweightOverweight
Jun 24, 2026Cantor FitzgeraldInitiated—Overweight
Jun 17, 2026HC Wainwright & Co.ReiteratedBuyBuy
Mar 13, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 16, 2025HC Wainwright & Co.ReiteratedBuyBuy
Aug 8, 2025Chardan CapitalMaintainedBuyBuy
Jun 13, 2025HC Wainwright & Co.ReiteratedBuyBuy
Jun 13, 2025Chardan CapitalMaintainedBuyBuy
May 9, 2025Goldman SachsMaintainedSellSell
May 9, 2025Morgan StanleyMaintainedOverweightOverweight
May 9, 2025Chardan CapitalMaintainedBuyBuy
Mar 7, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 5, 2025Morgan StanleyMaintainedOverweightOverweight
Mar 4, 2025BMO CapitalMaintainedOutperformOutperform
Mar 4, 2025Goldman SachsMaintainedSellSell
Feb 11, 2025Goldman SachsInitiated—Sell
Feb 3, 2025HC Wainwright & Co.ReiteratedBuyBuy
Jan 29, 2025HC Wainwright & Co.ReiteratedBuyBuy
Dec 10, 2024Chardan CapitalMaintainedBuyBuy
Dec 9, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 20, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 14, 2024Chardan CapitalMaintainedBuyBuy
Oct 8, 2024Morgan StanleyReiteratedOverweightOverweight
Aug 30, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 16, 2024Chardan CapitalMaintainedBuyBuy
Jun 28, 2024Morgan StanleyMaintainedOverweightOverweight
Jun 28, 2024Chardan CapitalMaintainedBuyBuy
Jun 27, 2024HC Wainwright & Co.ReiteratedBuyBuy